Medtronic plc — Director's Dealing 2021

Jun 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2021-06-18

Reporting Person: Wall Brett A. (EVP & Pres Neuroscience)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-18	Ordinary Shares	M	1168	$74.84	Acquired	22655	Direct
2021-06-18	Ordinary Shares	F	938	$123.23	Disposed	21717	Direct
2021-06-21	Ordinary Shares	S	115	$123.50	Disposed	21602	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-18	Stock Option (Right to Buy)	$74.84	M	1168	Disposed	2025-01-27	Ordinary Shares (1168)	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: This option became exercisable on June 29, 2018, subject to Medtronic plc's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018.